EU Regulators Warn of Counterfeit Copies of Cancer Drug Herceptin
EU regulators have issued a warning that several batches of the cancer medicine Herceptin (trastuzumab) have been “tampered with,” falsified and reintroduced into the supply chain, potentially putting patients at risk.
High-cost cancer medications like Herceptin have become an increasingly tempting target for thieves and counterfeiters in recent years. While they lack the ready market that some drugs like Viagra have, their extraordinary cost means extraordinary paydays. US officials warned of a similar scare in February 2012, when counterfeit copies of Roche’s Avastin (bevacizumab) were found to have infiltrated the US supply chain. Another batch of the counterfeit drug was found in April 2012.
In the wake of those findings, FDA went after more than a dozen physicians, who were blamed for purchasing the Avastin from unauthorized suppliers in the pursuit of higher profit margins.
Related Posts
Pretend wheelchair bound passenger arrested for gold smuggling
A male passenger acting as a disable person arrested for alleged gold smuggling...
Quantum cascade lasers ‘can detect falsified drugs’.
Researchers at the Fraunhofer Institute in Germany have developed a miniaturised...
A2IM Warns of Counterfeit CDs Across Amazon.com
Attention music shoppers: Some of those random sellers atop the price search...
Customs seizes P10-B counterfeit goods, smuggled rice
The Bureau of Customs (BOC) has seized in five warehouses in Quezon City over P10...